EUVIMEDEUVIMED entdecken
CrossrefInfokarte

288 Role of Aprepitant in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

Nameer Faiz, Ali MohamedAhmed, Mohamed Issa, Salma Mohammed

British Journal of Surgery · 2025-12-29 · 112 (Supplement_17)

DOI: 10.1093/bjs/znaf270.221 ↗
AbstractBibliografische Angaben

Abstract

Abstract Aim Is to investigate the role of Aprepitant in prevention of postoperative nausea and vomiting post LSG. Method A systematic online search was conducted using electronic databases. Comparative studies of Aprepitant (AP) versus No-Aprepitant (NAP) for preventing nausea and vomiting post-LSG were included. The primary outcome was vomiting in the first two hours and 24 hours post-LSG. The requirement of rescue anti-emetics during the first two and 24 hours were the evaluated secondary outcome parameters. The meta-analysis was performed using Rev Man version 5.3. Results Three studies with a total number of 812 patients were eligible to be included in this review; 408 patients received AP, and 404 patients were allocated to the NAP group. The AP group showed a significantly lower risk for postoperative vomiting at 2 and 24 hours [3% in the AP group vs 7% in the NAP group, Risk ratio (RR) 0.44, P-value = 0.04] and [4.7% in the AP group vs 14.4% in the NAP group (RR 0.33, P-value = 0.0001), respectively. Regarding rescue antiemetics, the NAP group showed a higher requirement for rescue antiemetics compared to the AP group at two hours [27.8% in the AP group vs 41.6% in the NAP group, RR 0.54, P-value = 0.002] and at 24 hours [4.7% in the AP group vs 14.9% in the NAP group, RR 0.20, P-value = 0.0001]. Conclusions Aprepitant provides excellent control of nausea and vomiting post-LSG. It decreases vomiting episodes and the requirement for further doses of anti-emetics, leading to better patient outcomes and satisfaction.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →